Literature DB >> 12832221

Brain sites of movement disorder: genetic and environmental agents in neurodevelopmental perturbations.

T Palomo1, R J Beninger, R M Kostrzewa, T Archer.   

Abstract

In assessing and assimilating the neurodevelopmental basis of the so-called movement disorders it is probably useful to establish certain concepts that will modulate both the variation and selection of affliction, mechanisms-processes and diversity of disease states. Both genetic, developmental and degenerative aberrations are to be encompassed within such an approach, as well as all deviations from the necessary components of behaviour that are generally understood to incorporate "normal" functioning. In the present treatise, both conditions of hyperactivity/hypoactivity, akinesia and bradykinesia together with a constellation of other symptoms and syndromes are considered in conjunction with the neuropharmacological and brain morphological alterations that may or may not accompany them, e.g. following neonatal denervation. As a case in point, the neuroanatomical and neurochemical points of interaction in Attention Deficit and Hyperactivity disorder (ADHD) are examined with reference to both the perinatal metallic and organic environment and genetic backgrounds. The role of apoptosis, as opposed to necrosis, in cell death during brain development necessitates careful considerations of the current explosion of evidence for brain nerve growth factors, neurotrophins and cytokines, and the processes regulating their appearance, release and fate. Some of these processes may possess putative inherited characteristics, like alpha-synuclein, others may to greater or lesser extents be endogenous or semi-endogenous (in food), like the tetrahydroisoquinolines, others exogenous until inhaled or injested through environmental accident, like heavy metals, e.g. mercury. Another central concept of neurodevelopment is cellular plasticity, thereby underlining the essential involvement of glutamate systems and N-methyl-D-aspartate receptor configurations. Finally, an essential assimilation of brain development in disease must delineate the relative merits of inherited as opposed to environmental risks not only for the commonly-regarded movement disorders, like Parkinson's disease, Huntington's disease and epilepsy, but also for afflictions bearing strong elements of psychosocial tragedy, like ADHD, autism and Savantism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832221     DOI: 10.1007/BF03033369

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.978


  385 in total

1.  Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits.

Authors:  J D Oh; C L Vaughan; T N Chase
Journal:  Brain Res       Date:  1999-03-13       Impact factor: 3.252

2.  Molecular genetics of familial parkinsonism.

Authors:  Z K Wszolek; K Markopoulou
Journal:  Parkinsonism Relat Disord       Date:  1999-12       Impact factor: 4.891

3.  Stereospecific occurrence of a parkinsonism-inducing catechol isoquinoline, N-methyl(R)salsolinol, in the human intraventricular fluid.

Authors:  W Maruyama; H Narabayashi; P Dostert; M Naoi
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  Complete genomic screen in Parkinson disease: evidence for multiple genes.

Authors:  W K Scott; M A Nance; R L Watts; J P Hubble; W C Koller; K Lyons; R Pahwa; M B Stern; A Colcher; B C Hiner; J Jankovic; W G Ondo; F H Allen; C G Goetz; G W Small; D Masterman; F Mastaglia; N G Laing; J M Stajich; B Slotterbeck; M W Booze; R C Ribble; E Rampersaud; S G West; R A Gibson; L T Middleton; A D Roses; J L Haines; B L Scott; J M Vance; M A Pericak-Vance
Journal:  JAMA       Date:  2001-11-14       Impact factor: 56.272

5.  Environmental and genetic risk factors in Parkinson's disease: a case-control study in southern Italy.

Authors:  G De Michele; A Filla; G Volpe; V De Marco; A Gogliettino; G Ambrosio; R Marconi; A E Castellano; G Campanella
Journal:  Mov Disord       Date:  1996-01       Impact factor: 10.338

6.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

7.  Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder.

Authors:  F X Castellanos; J N Giedd; W L Marsh; S D Hamburger; A C Vaituzis; D P Dickstein; S E Sarfatti; Y C Vauss; J W Snell; N Lange; D Kaysen; A L Krain; G F Ritchie; J C Rajapakse; J L Rapoport
Journal:  Arch Gen Psychiatry       Date:  1996-07

Review 8.  Neurodevelopmental liabilities in epilepsy.

Authors:  Antonio Gil-Nagel
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

Review 9.  Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease.

Authors:  K S McNaught; P A Carrupt; C Altomare; S Cellamare; A Carotti; B Testa; P Jenner; C D Marsden
Journal:  Biochem Pharmacol       Date:  1998-10-15       Impact factor: 5.858

10.  Risk factors for Parkinson's disease.

Authors:  J P Hubble; T Cao; R E Hassanein; J S Neuberger; W C Koller
Journal:  Neurology       Date:  1993-09       Impact factor: 9.910

View more
  10 in total

1.  Development of neurological reflexes and motor coordination in rats neonatally treated with monosodium glutamate.

Authors:  P Kiss; A Tamas; A Lubics; M Szalai; L Szalontay; I Lengvari; D Reglodi
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

Review 2.  Gene-environment interplay in neurogenesis and neurodegeneration.

Authors:  Tomás Palomo; Trevor Archer; Richard J Beninger; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

3.  Neurobehavioural deficits associated with apoptotic neurodegeneration and vulnerability for ADHD.

Authors:  Anders Fredriksson; Trevor Archer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

4.  Changes in open-field activity and novelty-seeking behavior in periadolescent rats neonatally treated with monosodium glutamate.

Authors:  P Kiss; D Hauser; A Tamás; A Lubics; B Rácz; Z S Horvath; J Farkas; F Zimmermann; A Stepien; I Lengvari; D Reglódi
Journal:  Neurotox Res       Date:  2007-09       Impact factor: 3.911

5.  Dopamine regulates the expression of the glutamate transporter GLT1 but not GLAST in developing striatal astrocytes.

Authors:  Veronica I Brito; Verena E Rozanski; Cordian Beyer; Eva Küppers
Journal:  J Mol Neurosci       Date:  2009-08-15       Impact factor: 3.444

6.  Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders.

Authors:  Derrick F Macfabe
Journal:  Microb Ecol Health Dis       Date:  2012-08-24

7.  The neurotoxic effect of clindamycin - induced gut bacterial imbalance and orally administered propionic acid on DNA damage assessed by the comet assay: protective potency of carnosine and carnitine.

Authors:  Afaf El-Ansary; Ghada H Shaker; Amina R El-Gezeery; Laila Al-Ayadhi
Journal:  Gut Pathog       Date:  2013-04-12       Impact factor: 4.181

8.  Ontogenetic alterations in molecular and structural correlates of dendritic growth after developmental exposure to polychlorinated biphenyls.

Authors:  Pamela J Lein; Dongren Yang; Adam D Bachstetter; Hugh A Tilson; G Jean Harry; Ronald F Mervis; Prasada Rao S Kodavanti
Journal:  Environ Health Perspect       Date:  2007-01-16       Impact factor: 9.031

9.  Paraquat exposure induces behavioral deficits in larval zebrafish during the window of dopamine neurogenesis.

Authors:  Jayshree Nellore; Nandita P
Journal:  Toxicol Rep       Date:  2015-06-16

10.  Maternal Ferritin Levels during Pregnancy and ADHD Symptoms in 4-Year-Old Children: Results from the INMA-INfancia y Medio Ambiente (Environment and Childhood) Prospective Birth Cohort Study.

Authors:  Loreto Santa-Marina; Nerea Lertxundi; Ainara Andiarena; Amaia Irizar; Jordi Sunyer; Amaia Molinuevo; Sabrina Llop; Jordi Julvez; Andrea Beneito; Jesús Ibarluzea; Liher Imaz; Maite Ferrin
Journal:  Int J Environ Res Public Health       Date:  2020-10-22       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.